Figure 3

(a) In the test cohort there was no difference in the FGFR3 expression in the CDKN2A expression groups. (b) In the TCGA cohort FGFR3 was significantly lower expressed in CDKN2A^high tumours. CDKN2A^low tumours had also a higher expression of ESR2 (c). (*p < 0.05; **p < 0.01; ***p < 0.001).